<?xml version="1.0" encoding="UTF-8"?>
			
			<rss version="2.0">
				<channel>
					<title>Press Releases</title>
					<link>http://www.healthcarerepublic.com/</link>
					<description>Latest Press Releases from Healthcare Republic</description>
					<language>en</language>
					<lastBuildDate>Sat, 30 Aug 2008 06:26:42 GMT</lastBuildDate>
					<managingEditor>healthcarerepublic@mail4.haymarketbusinessinteractive.com</managingEditor>
					<webMaster>healthcarerepublic@mail4.haymarketbusinessinteractive.com</webMaster>
					
					<item>
					<title><![CDATA[New treatment launched to help improve symptoms in people suffering from overactive bladder]]></title>
					<link>http://www.healthcarerepublic.com/rss/pressrelease/842198/New-treatment-launched-help-improve-symptoms-people-suffering-overactive-bladder/</link>
					<description><![CDATA[Pfizer Limited has launched Toviaz(R)(Black Triangle Drug) (fesoterodine fumarate), a new once daily treatment for the symptoms of overactive bladder(OAB).]]></description>
					
					<pubDate>Thu, 28 Aug 2008 10:39:00 GMT</pubDate>
				</item>				
			
				
				
				<item>
					<title><![CDATA[The University of Nottingham announces a breakthrough in Parkinson's disease research]]></title>
					<link>http://www.healthcarerepublic.com/rss/pressrelease/842201/University-Nottingham-announces-breakthrough-Parkinsons-disease-research/</link>
					<description><![CDATA[Award winning research team makes crucial breakthrough in battle to prevent onset of Parkinson's disease]]></description>
					
					<pubDate>Thu, 28 Aug 2008 10:44:00 GMT</pubDate>
				</item>				
			
				
				
				<item>
					<title><![CDATA[Cook Medical Drives Discussion on Peyronie's Disease]]></title>
					<link>http://www.healthcarerepublic.com/rss/pressrelease/839141/Cook-Medical-Drives-Discussion-Peyronies-Disease/</link>
					<description><![CDATA[In its ongoing commitment to remain at the forefront of physician and patient education, Cook Medical today announced that new resources are available on MensHealthPD.com including Q&A videos featuring three new expert physicians, updated medical research and multiple links to accredited industry sites]]></description>
					
					<pubDate>Wed, 13 Aug 2008 12:29:00 GMT</pubDate>
				</item>				
			
				
				
				<item>
					<title><![CDATA[Health services respond to Shipman inquiry with better monitoring of controlled drugs]]></title>
					<link>http://www.healthcarerepublic.com/rss/pressrelease/836208/Health-services-respond-Shipman-inquiry-better-monitoring-controlled-drugs/</link>
					<description><![CDATA[NHS and private healthcare providers have taken positive steps to improve the monitoring and management of controlled drugs following the Shipman Inquiry.]]></description>
					
					<pubDate>Thu, 31 Jul 2008 12:43:00 GMT</pubDate>
				</item>				
			
				
				
				<item>
					<title><![CDATA[Clinicians Trending toward Using Technology to Manage and Monitor Patient Treatment]]></title>
					<link>http://www.healthcarerepublic.com/rss/pressrelease/835543/Clinicians-Trending-toward-Using-Technology-Manage-Monitor-Patient-Treatment/</link>
					<description><![CDATA[Increasingly, health care clinicians are using technology to manage diseases and patients, according to Syd Stewart, managing director of UK-based 4S Information Systems Ltd.]]></description>
					
					<pubDate>Wed, 30 Jul 2008 12:53:00 GMT</pubDate>
				</item>				
			
				
				
				<item>
					<title><![CDATA['Tredaptive' authorised in the EU]]></title>
					<link>http://www.healthcarerepublic.com/rss/pressrelease/834324/Tredaptive-authorised-EU/</link>
					<description><![CDATA[Merck Sharp & Dohme Limited (MSD) announced today that 'Tredaptive' (nicotinic acid/laropiprant) 1000 mg/20 mg modified-release tablets, a new lipid-modifying therapy for patients with dyslipidaemia and primary
hypercholesterolaemia, has been authorised for marketing in the 27 member countries of the European Union (EU) and Iceland and Norway.]]></description>
					
					<pubDate>Thu, 24 Jul 2008 15:51:00 GMT</pubDate>
				</item>
				</channel>
			</rss>